These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12008671)

  • 21. Pharmacokinetic evaluation of capecitabine in breast cancer.
    Daniele G; Gallo M; Piccirillo MC; Giordano P; D'Alessio A; Del Giudice A; La Porta ML; Perrone F; Normanno N; De Luca A
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):225-35. PubMed ID: 23301520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evolving role for oral fluoropyrimidine drugs.
    Diasio RB
    J Clin Oncol; 2002 Feb; 20(4):894-6. PubMed ID: 11844808
    [No Abstract]   [Full Text] [Related]  

  • 23. Response of neoplastic meningitis from solid tumors to oral capecitabine.
    Giglio P; Tremont-Lukats IW; Groves MD
    J Neurooncol; 2003 Nov; 65(2):167-72. PubMed ID: 14686737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy in older women with breast cancer.
    Dizdar O; Dede DS; Altundag K
    N Engl J Med; 2009 Sep; 361(10):1023; author reply 1023-4. PubMed ID: 19731412
    [No Abstract]   [Full Text] [Related]  

  • 25. Capecitabine in the treatment of colorectal cancer.
    O'Neill VJ; Cassidy J
    Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
    Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficiency of the capecitabine in patients with breast cancer with liver metastasis].
    Gasanzade DA; Zeĭnalov RS; Musaev IN
    Georgian Med News; 2009; (172-173):13-6. PubMed ID: 19644181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy in older women with breast cancer.
    Zeng YC
    N Engl J Med; 2009 Sep; 361(10):1023; author reply 1023-4. PubMed ID: 19726778
    [No Abstract]   [Full Text] [Related]  

  • 29. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.
    Ou SH; Holcombe RF
    Drugs; 2007; 67(4):611-2. PubMed ID: 17352521
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete response of brain metastases originating in breast cancer to capecitabine therapy.
    Siegelmann-Danieli N; Stein M; Bar-Ziv J
    Isr Med Assoc J; 2003 Nov; 5(11):833-4. PubMed ID: 14650117
    [No Abstract]   [Full Text] [Related]  

  • 31. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
    Barrett-Lee P; Bidard FC; Pierga JY
    Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
    Bel B; Lorton MH; Darut-Jouve A; Vabres P
    Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
    Fabi A; Metro G; Papaldo P; Mottolese M; Melucci E; Carlini P; Sperduti I; Russillo M; Gelibter A; Ferretti G; Tomao S; Milella M; Cognetti F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):717-25. PubMed ID: 18071704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Doxifluridine for treatment of colorectal cancer].
    Nishimura G; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
    Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature.
    Minisini AM; Pauletto G; Bergonzi P; Fasola G
    Breast Cancer Res Treat; 2007 Oct; 105(2):133-8. PubMed ID: 17123150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capecitabine dosing is not yet optimized for breast cancer.
    Hudis C; Traina T; Norton L
    Ann Oncol; 2010 Nov; 21(11):2291; author reply 2291-2. PubMed ID: 20501505
    [No Abstract]   [Full Text] [Related]  

  • 39. Reporting of adjuvant breast cancer trials: when is the right time?
    Earl HM
    J Clin Oncol; 2012 Jan; 30(1):1-2. PubMed ID: 22105825
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.
    Van Cutsem E; Verslype C; Tejpar S
    Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.